CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 8,484 shares at an average $47.07 ($399,351)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 4,157 shares at $46.53 ($193,418)
- 4 Open-market sale GENERAL COUNSEL sold 9,580 shares at $46.53 ($445,740)
- 4 Open-market sale CHRO sold 9,035 shares at $46.53 ($420,382)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 7,989 shares at $46.53 ($371,714)
- 4 Grant or award President of R&D acquired 47,021 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 47,021 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 29,258 shares (grant or award)
- 4 Grant or award Chief Human Resources Officer acquired 29,258 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 34,482 shares (grant or award)
- 4 Grant or award General Counsel acquired 36,572 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 128,004 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 47,021 shares (grant or award)
- 4 Option exercise 10% owner acquired 1,575,008 shares (option exercise)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 14,898 shares at an average $46.71 ($695,938)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 8,406 shares at $44.48 ($373,880)
- 4 Open-market sale CHRO sold 6,600 shares at $44.48 ($293,553)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 5,798 shares at $44.48 ($257,882)
- 4 Open-market sale GENERAL COUNSEL sold 8,016 shares at $44.48 ($356,533)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 13,112 shares at $45.20 ($592,611)
Page 2 of 17 · 321 filings